Repligen (RGEN) Other Accumulated Expenses (2011 - 2026)

Repligen (RGEN) has 15 years of Other Accumulated Expenses data on file, last reported at $19.8 million in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $19.8 million, down 9.7% year-over-year; the trailing twelve-month figure through Mar 2026 was $19.8 million (down 9.7% YoY), and the FY2025 annual result was $20.9 million, up 33.81% from the prior year.
• Other Accumulated Expenses slipped to $19.8 million in Q1 2026 per RGEN's latest filing, from $20.9 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $22.7 million in Q3 2025 and troughed at $14.7 million in Q2 2023.
• A 5-year average of $17.8 million and a median of $16.8 million in 2023 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses soared 1950.98% in 2022, then decreased 13.08% in 2023.
• A 5-year view of Other Accumulated Expenses shows it stood at $15.9 million in 2022, then grew by 5.78% to $16.8 million in 2023, then decreased by 7.02% to $15.6 million in 2024, then soared by 33.81% to $20.9 million in 2025, then dropped by 5.24% to $19.8 million in 2026.
• Business Quant data shows RGEN's Other Accumulated Expenses at $19.8 million in Q1 2026, $20.9 million in Q4 2025, and $22.7 million in Q3 2025.